• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Immunotherapy - Articles and news items

vaccine

How Panacea is paving the way for vaccine immunotherapies

Blog, Z Homepage promo / 29 March 2017 / Niamh Marriott, Junior Editor

We caught up with the CEO & CSO of Panacea for the latest on vaccine immunotherapies – “As a scientist, as long as you are observant and persistent, you may come up with breakthrough discoveries”

bladder cancer

Immunotherapy treatment fast-tracked under UK’s access to medicines scheme

Industry news / 2 February 2017 / Niamh Marriott, Digital Editor

From today, UK patients with an incurable form of bladder cancer can access the new immunotherapy, atezolizumab, following a positive Scientific Opinion…

Up to 10-fold increase in assay sensitivity - discover Morffi™ at MEDICA 2016

Up to 10-fold increase in assay sensitivity – discover Morffi™ at MEDICA 2016

Supplier news / 3 November 2016 / BBI Solutions

BBI Solutions will be showcasing its Morffi™ signal enhancement technology on Stand F26 in Hall 1 at MEDICA 2016…

head and neck cancer

‘Game-changing’ immunotherapy doubles head and neck cancer survival

Industry news, Z Homepage promo / 10 October 2016 / Niamh Louise Marriott, Digital Content Producer

An immunotherapy drug has been hailed as a ‘game changer’ after being found to greatly improve survival for patients with relapsed head and neck cancer…

BBI Solutions launches innovative conjugate blocking technology that enhances signal intensity for lateral flow immunoassays

BBI Solutions launches innovative conjugate blocking technology that enhances signal intensity for lateral flow immunoassays

Supplier news / 23 September 2016 / BBI Solutions

BBI Solutions has launched Morffi™, a novel conjugate blocking technology that enhances signal intensity and improves the sensitivity of lateral flow immunoassays, at the Lateral Flow Test Development seminar in Seattle, USA, on the 20th September…

Cancer immunotherapy drugs linked to autoimmune diseases

Industry news / 24 June 2016 / Victoria White, Digital Content Producer

Some cancer patients taking the immunotherapy drugs ipilimumab and nivolumab may be at a higher-than-normal risk of developing autoimmune diseases…

Chemo may boost immunotherapy power in ovarian cancer

Industry news / 15 June 2016 / Victoria White, Digital Content Producer

A study has found that women with ovarian cancer may benefit more from immunotherapy drug treatments if they are given straight after chemotherapy…

Study describes extraordinarily potent mRNA cancer immunotherapy

Industry news / 2 June 2016 / Victoria White, Digital Content Producer

BioNTech has announced the publication of a study that describes the first example of a clinically relevant and systemic mRNA cancer immunotherapy…

Positive interim review in ongoing AML WT1 T cell clinical trial

Industry news / 14 April 2016 / Victoria White, Digital Content Producer

The Cell and Gene Therapy Catapult has announced a positive interim review of a Phase I/II trial using WT1-TCR t-cell therapy to target acute myeloid leukaemia…

Forecasting in dynamic Oncology Markets

Supplier news / 14 March 2016 / Black Swan Analysis

Two big things struck me as interesting during an Innovations in Oncology Conference in Edinburgh this month…

Researchers make cancer immunotherapy ‘breakthrough’

Industry news / 4 March 2016 / Victoria White

Researchers have found the tools necessary to give immunotherapy the precision guidance that patients with cancer so desperately need…

Multiparameter profiling of a Structure Activity Relationship (SAR) library for immunological activity in human PBMCs

Application Note: Multiparameter profiling of a Structure Activity Relationship (SAR) library for immunological activity in human PBMCs

Whitepapers / 15 January 2016 / IntelliCyt

We describe a no-wash, high throughput screen that provides a multiparametric activity profile for a structure activity relationship (SAR) library derived from immunomodulatory compounds…